{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:04:03Z","timestamp":1793639043577,"version":"4.5.1"},"reference-count":100,"publisher":"American Society of Hematology","issue":"6","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,8,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Transplantation-associated thrombotic microangiopathy (TA-TMA) is a challenging diagnosis after hematopoietic stem cell transplantation. Although endothelial injury represents the final common pathway of disease, the exact pathophysiology of TA-TMA remains unclear. Potential causes include infections, chemotherapy, radiation, and calcineurin inhibitors. Recent literature addresses the roles of cytokines, graft-versus-host disease, the coagulation cascade, and complement in the pathogenesis of TA-TMA. Current diagnostic criteria are unsatisfactory, because patients who have received a transplant can have multiple other reasons for the laboratory abnormalities currently used to diagnose TA-TMA. Moreover, our lack of understanding of the exact mechanism of disease limits the development and evaluation of potential treatments. Short- and long-term renal complications contribute to TA-TMA's overall poor prognosis. In light of these challenges, future research must validate novel markers of disease to aid in early diagnosis, guide current and future treatments, prevent long-term morbidity, and improve outcomes. We focus on TA-TMA as a distinct complication of hematopoietic stem cell transplantation, emphasizing the central role of the kidney in this disease.<\/jats:p>","DOI":"10.1182\/blood-2011-02-321315","type":"journal-article","created":{"date-parts":[[2011,5,20]],"date-time":"2011-05-20T05:19:37Z","timestamp":1305868777000},"page":"1452-1462","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":282,"title":["Small vessels, big trouble in the kidneys and beyond: hematopoietic stem cell transplantation\u2013associated thrombotic microangiopathy"],"prefix":"10.1182","volume":"118","author":[{"given":"Benjamin L.","family":"Laskin","sequence":"first","affiliation":[{"name":"Divisions of Nephrology and Hypertension and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Goebel","sequence":"additional","affiliation":[{"name":"Divisions of Nephrology and Hypertension and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella M.","family":"Davies","sequence":"additional","affiliation":[{"name":"Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children's Hospital Medical Center, Cincinnati, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonata","family":"Jodele","sequence":"additional","affiliation":[{"name":"Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children's Hospital Medical Center, Cincinnati, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"4","key":"2019111807521444600_B1","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00467-010-1637-4","article-title":"Advances in our understanding of the pathogenesis of glomerular thrombotic microangiopathy.","volume":"26","author":"Keir","year":"2011","journal-title":"Pediatr Nephrol"},{"issue":"2","key":"2019111807521444600_B2","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2215\/CJN.02070508","article-title":"Renal thrombotic microangiopathy after hematopoietic cell transplant: role of GVHD in pathogenesis.","volume":"4","author":"Changsirikulchai","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"2019111807521444600_B3","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/01.tp.0000297998.33418.7e","article-title":"Thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation: an autopsy study.","volume":"85","author":"Siami","year":"2008","journal-title":"Transplantation"},{"issue":"4","key":"2019111807521444600_B4","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1440-1797.2007.00915.x","article-title":"Clinicopathologic analysis of renal biopsies after haematopoietic stem cell transplantation.","volume":"13","author":"Chan","year":"2008","journal-title":"Nephrology (Carlton)"},{"issue":"8","key":"2019111807521444600_B5","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/sj.bmt.1705758","article-title":"Diagnosis and treatment of transplantation-associated thrombotic microangiopathy: real progress or are we still waiting?","volume":"40","author":"Batts","year":"2007","journal-title":"Bone Marrow Transplant"},{"issue":"11","key":"2019111807521444600_B6","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/bmt.2008.7","article-title":"Hematopoietic stem cell transplantation-associated thrombotic microangiopathy: defining a disorder.","volume":"41","author":"George","year":"2008","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"2019111807521444600_B7","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1537-2995.2004.00700.x","article-title":"Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome following allogeneic HPC transplantation: a diagnostic dilemma.","volume":"44","author":"George","year":"2004","journal-title":"Transfusion"},{"issue":"1","key":"2019111807521444600_B8","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.transproceed.2005.12.040","article-title":"Thrombotic nephropathy and pulmonary hypertension following autologous bone marrow transplantation in a patient with acute lymphoblastic leukemia: case report.","volume":"38","author":"Perkowska-Ptasinska","year":"2006","journal-title":"Transplant Proc"},{"issue":"2","key":"2019111807521444600_B9","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/CCO.0b013e3280148a2f","article-title":"Thrombotic microangiopathy following allogeneic hematopoietic stem cell transplantation.","volume":"19","author":"Kojouri","year":"2007","journal-title":"Curr Opin Oncol"},{"issue":"2","key":"2019111807521444600_B10","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.beha.2008.02.002","article-title":"Vascular endothelium as \u2018novel\u2019 target of graft-versus-host disease.","volume":"21","author":"Tichelli","year":"2008","journal-title":"Best Pract Res Clin Haematol"},{"issue":"5","key":"2019111807521444600_B11","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.2215\/CJN.01700407","article-title":"Spectrum of renal pathology in hematopoietic cell transplantation: a series of 20 patients and review of the literature.","volume":"2","author":"Chang","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"issue":"112","key":"2019111807521444600_B12","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1038\/ki.2008.629","article-title":"A Canadian phase II study evaluating the efficacy of rituximab in the management of patients with relapsed\/refractory thrombotic thrombocytopenic purpura.","author":"Foley","year":"2009","journal-title":"Kidney Int Suppl"},{"issue":"5","key":"2019111807521444600_B13","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/bmt.2010.182","article-title":"Early clinical indicators of transplant-associated thrombotic microangiopathy in pediatric neuroblastoma patients undergoing auto-SCT.","volume":"45","author":"Laskin","year":"2011","journal-title":"Bone Marrow Transplant"},{"issue":"7","key":"2019111807521444600_B14","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/ajh.20648","article-title":"Risk factor analysis for thrombotic microangiopathy after reduced-intensity or myeloablative allogeneic hematopoietic stem cell transplantation.","volume":"81","author":"Nakamae","year":"2006","journal-title":"Am J Hematol"},{"issue":"11","key":"2019111807521444600_B15","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.bbmt.2005.07.012","article-title":"Hemolytic uremic syndrome after bone marrow transplantation: clinical characteristics and outcome in children.","volume":"11","author":"Hale","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"2019111807521444600_B16","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.transci.2007.03.004","article-title":"ABO-incompatible allogeneic hematopoietic stem cell transplantation following reduced-intensity conditioning: close association with transplant-associated microangiopathy.","volume":"36","author":"Worel","year":"2007","journal-title":"Transfus Apher Sci"},{"issue":"4","key":"2019111807521444600_B17","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/bmt.2009.230","article-title":"Comparison of thrombotic microangiopathy after allogeneic hematopoietic cell transplantation with high-dose or nonmyeloablative conditioning.","volume":"45","author":"Willems","year":"2010","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"2019111807521444600_B18","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.bbmt.2005.06.001","article-title":"Blood and marrow transplant clinical trials network toxicity committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantation.","volume":"11","author":"Ho","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"2019111807521444600_B19","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1097\/01.tp.0000230373.82376.46","article-title":"Risk factors and severe outcome in thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation.","volume":"82","author":"Uderzo","year":"2006","journal-title":"Transplantation"},{"issue":"11","key":"2019111807521444600_B20","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1056\/NEJMoa0707330","article-title":"VEGF inhibition and renal thrombotic microangiopathy.","volume":"358","author":"Eremina","year":"2008","journal-title":"N Engl J Med"},{"issue":"4","key":"2019111807521444600_B21","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/sj.bmt.1702517","article-title":"Complications after bone marrow transplantation are manifestations of systemic inflammatory response syndrome.","volume":"26","author":"Takatsuka","year":"2000","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"2019111807521444600_B22","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1399-3062.2010.00581.x","article-title":"BK virus encephalitis with thrombotic microangiopathy in an allogeneic hematopoietic stem cell transplant recipient.","volume":"13","author":"Lopes da Silva","year":"2011","journal-title":"Transpl Infect Dis"},{"key":"2019111807521444600_B23","article-title":"Blood, and not urine, BK viral load predicts renal outcome in children with hemorrhagic cystitis following hematopoietic stem cell transplantation [published online ahead of print March 7, 2011].","author":"Haines","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"2019111807521444600_B24","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/pbc.22861","article-title":"Transplant-associated thrombotic microangiopathy in pediatric patients treated with sirolimus and tacrolimus.","volume":"57","author":"Rosenthal","year":"2011","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"2019111807521444600_B25","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1053\/ajkd.2003.50058","article-title":"De novo thrombotic microangiopathy in renal transplant recipients: a comparison of hemolytic uremic syndrome with localized renal thrombotic microangiopathy.","volume":"41","author":"Schwimmer","year":"2003","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"2019111807521444600_B26","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1053\/j.ajkd.2010.06.006","article-title":"The role of endothelial cell injury in thrombotic microangiopathy.","volume":"56","author":"Goldberg","year":"2010","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"2019111807521444600_B27","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/bmt.2008.350","article-title":"Nitric oxide in transplantation-related thrombotic microangiopathy.","volume":"43","author":"Thachil","year":"2009","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"2019111807521444600_B28","doi-asserted-by":"crossref","first-page":"335","DOI":"10.5414\/CNP67335","article-title":"De novo thrombotic microangiopathy. An underrated complication of renal transplantation.","volume":"67","author":"Ponticelli","year":"2007","journal-title":"Clin Nephrol"},{"issue":"5","key":"2019111807521444600_B29","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1182\/blood-2009-03-207563","article-title":"A phase II pilot study of tacrolimus\/sirolimus GVHD prophylaxis for sibling donor hematopoietic stem cell transplantation using 3 conditioning regimens.","volume":"115","author":"Rodriguez","year":"2010","journal-title":"Blood"},{"issue":"7","key":"2019111807521444600_B30","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.bbmt.2005.04.007","article-title":"Sirolimus and thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation.","volume":"11","author":"Cutler","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"2019111807521444600_B31","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.bbmt.2008.11.004","article-title":"Graft-versus-host disease prophylaxis with everolimus and tacrolimus is associated with a high incidence of sinusoidal obstruction syndrome and microangiopathy: results of the EVTAC trial.","volume":"15","author":"Platzbecker","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"issue":"8","key":"2019111807521444600_B32","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.bbmt.2007.04.007","article-title":"Vascular endothelial growth factor and activin-a serum levels following allogeneic hematopoietic stem cell transplantation.","volume":"13","author":"Nachbaur","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"2019111807521444600_B33","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/sj.bmt.1705410","article-title":"Vascular endothelial growth factor (VEGF) is associated with reduced severity of acute graft-versus-host disease and nonrelapse mortality after allogeneic stem cell transplantation.","volume":"38","author":"Min","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"2019111807521444600_B34","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.bbmt.2007.10.008","article-title":"The contribution of endothelial activation and injury to end-organ toxicity following allogeneic hematopoietic stem cell transplantation.","volume":"14","author":"Cooke","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"2019111807521444600_B35","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.beha.2008.02.003","article-title":"Vascular endothelium and graft-versus-host disease.","volume":"21","author":"Biedermann","year":"2008","journal-title":"Best Pract Res Clin Haematol"},{"issue":"12","key":"2019111807521444600_B36","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.bbmt.2008.09.015","article-title":"Albuminuria in hematopoietic cell transplantation patients: prevalence, clinical associations, and impact on survival.","volume":"14","author":"Hingorani","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"2019111807521444600_B37","doi-asserted-by":"crossref","first-page":"685","DOI":"10.2215\/CJN.00380705","article-title":"Nephrotic syndrome after hematopoietic cell transplantation: do glomerular lesions represent renal graft-versus-host disease?","volume":"1","author":"Brukamp","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9","key":"2019111807521444600_B38","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/sj.bmt.1705976","article-title":"Clinical impact of thrombotic microangiopathy on the outcome of patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.","volume":"41","author":"Cho","year":"2008","journal-title":"Bone Marrow Transplant"},{"issue":"7","key":"2019111807521444600_B39","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1681\/ASN.2006020118","article-title":"Chronic kidney disease in long-term survivors of hematopoietic cell transplantation: epidemiology, pathogenesis, and treatment.","volume":"17","author":"Hingorani","year":"2006","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"2019111807521444600_B40","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1440-1827.2010.02608.x","article-title":"Renal thrombotic microangiopathy associated with chronic humoral graft versus host disease after hematopoietic stem cell transplantation.","volume":"61","author":"Mii","year":"2011","journal-title":"Pathol Int"},{"issue":"6","key":"2019111807521444600_B41","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/j.1365-2141.2007.06515.x","article-title":"Nephrotic syndrome associated with thrombotic microangiopathy following allogeneic stem-cell transplantation for myelodysplastic syndrome.","volume":"136","author":"Nakamura","year":"2007","journal-title":"Br J Haematol"},{"issue":"2","key":"2019111807521444600_B42","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/10245330600574219","article-title":"Heparin cofactor II as a predictor of thrombotic microangiopathy after bone marrow transplantation.","volume":"11","author":"Takatsuka","year":"2006","journal-title":"Hematology"},{"issue":"4","key":"2019111807521444600_B43","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1053\/j.ajkd.2006.06.013","article-title":"Circulating endothelial cells as a prognostic marker in thrombotic microangiopathy.","volume":"48","author":"Erdbruegger","year":"2006","journal-title":"Am J Kidney Dis"},{"issue":"17","key":"2019111807521444600_B44","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1056\/NEJMra0902814","article-title":"Atypical hemolytic-uremic syndrome.","volume":"361","author":"Noris","year":"2009","journal-title":"N Engl J Med"},{"issue":"1","key":"2019111807521444600_B45","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00467-010-1556-4","article-title":"aHUS caused by complement dysregulation: new therapies on the horizon.","volume":"26","author":"Waters","year":"2011","journal-title":"Pediatr Nephrol"},{"issue":"2","key":"2019111807521444600_B46","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1182\/blood-2009-05-221549","article-title":"Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome.","volume":"115","author":"Moore","year":"2010","journal-title":"Blood"},{"issue":"10","key":"2019111807521444600_B47","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1007\/s00467-010-1446-9","article-title":"DEAP-HUS: deficiency of CFHR plasma proteins and autoantibody-positive form of hemolytic uremic syndrome.","volume":"25","author":"Zipfel","year":"2010","journal-title":"Pediatr Nephrol"},{"key":"2019111807521444600_B48","article-title":"Successful early intervention for hyperacute transplant-associated thrombotic microangiopathy following pediatric hematopoietic stem cell transplantation [published online ahead of print November 5, 2010].","author":"Jodele","journal-title":"Pediatr Transplant"},{"issue":"4","key":"2019111807521444600_B49","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1681\/ASN.2007010073","article-title":"Antibody-mediated renal allograft rejection: diagnosis and pathogenesis.","volume":"18","author":"Colvin","year":"2007","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"2019111807521444600_B50","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1056\/NEJMoa035717","article-title":"Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection.","volume":"352","author":"Dragun","year":"2005","journal-title":"N Engl J Med"},{"issue":"1","key":"2019111807521444600_B51","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1182\/blood.V100.1.334","article-title":"Fludarabine induces apoptosis, activation, and allogenicity in human endothelial and epithelial cells: protective effect of defibrotide.","volume":"100","author":"Eissner","year":"2002","journal-title":"Blood"},{"issue":"3","key":"2019111807521444600_B52","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1365-2141.2008.07324.x","article-title":"Advances in understanding of pathogenesis of aHUS and HELLP.","volume":"143","author":"Fang","year":"2008","journal-title":"Br J Haematol"},{"issue":"8","key":"2019111807521444600_B53","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1097\/TP.0b013e3181f24e8d","article-title":"Validation of recently proposed consensus criteria for thrombotic microangiopathy after allogeneic hematopoietic stem-cell transplantation.","volume":"90","author":"Cho","year":"2010","journal-title":"Transplantation"},{"issue":"9","key":"2019111807521444600_B54","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1111\/j.1600-6143.2010.03224.x","article-title":"Biopsy-diagnosed renal disease in patients after transplantation of other organs and tissues.","volume":"10","author":"Schwarz","year":"2010","journal-title":"Am J Transplant"},{"issue":"4","key":"2019111807521444600_B55","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/modpathol.3801011","article-title":"Renal pathology in hematopoietic cell transplantation recipients.","volume":"21","author":"Troxell","year":"2008","journal-title":"Mod Pathol"},{"issue":"3","key":"2019111807521444600_B56","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1600-0609.2009.01267.x","article-title":"Intestinal perforation secondary to haematopoietic stem cell transplant associated thrombotic microangiopathy.","volume":"83","author":"Hewamana","year":"2009","journal-title":"Eur J Haematol"},{"issue":"1","key":"2019111807521444600_B57","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/bmt.2008.419","article-title":"Clinicopathological manifestations and treatment of intestinal transplant-associated microangiopathy.","volume":"44","author":"Inamoto","year":"2009","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"2019111807521444600_B58","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3324\/haematol.10699","article-title":"Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: results of a consensus process by an International Working Group.","volume":"92","author":"Ruutu","year":"2007","journal-title":"Haematologica"},{"issue":"11","key":"2019111807521444600_B59","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S1083-8791(03)00243-X","article-title":"Renal pathology at autopsy in patients who died after hematopoietic stem cell transplantation.","volume":"9","author":"El-Seisi","year":"2003","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7","key":"2019111807521444600_B60","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.bbmt.2010.02.006","article-title":"Chronic kidney disease, thrombotic microangiopathy, and hypertension following T cell-depleted hematopoietic stem cell transplantation.","volume":"16","author":"Glezerman","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"2019111807521444600_B61","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.bbmt.2007.11.008","article-title":"Chronic kidney disease after pediatric hematopoietic cell transplant.","volume":"14","author":"Hingorani","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"2019111807521444600_B62","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/pbc.22506","article-title":"Is the updated Schwartz formula appropriate for assessing renal function prior to hematopoietic stem cell transplantation?","volume":"55","author":"Qayed","year":"2010","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"2019111807521444600_B63","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s12185-010-0521-0","article-title":"Cystatin C level as a marker of renal function in allogeneic hematopoietic stem cell transplantation.","volume":"91","author":"Muto","year":"2010","journal-title":"Int J Hematol"},{"issue":"1","key":"2019111807521444600_B64","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1523-1755.2005.00078.x","article-title":"Acute renal failure after myeloablative hematopoietic cell transplant: incidence and risk factors.","volume":"67","author":"Hingorani","year":"2005","journal-title":"Kidney Int"},{"issue":"2","key":"2019111807521444600_B65","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/BF02983218","article-title":"Clinical significance of fragmented red cells after allogeneic bone marrow transplantation.","volume":"77","author":"Kanamori","year":"2003","journal-title":"Int J Hematol"},{"issue":"9","key":"2019111807521444600_B66","doi-asserted-by":"crossref","first-page":"651","DOI":"10.3858\/emm.2010.42.9.065","article-title":"Change in serum proteome during allogeneic hematopoietic stem cell transplantation and clinical significance of serum C-reactive protein and haptoglobin.","volume":"42","author":"Ryu","year":"2010","journal-title":"Exp Mol Med"},{"issue":"12","key":"2019111807521444600_B67","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1038\/ki.2010.322","article-title":"Urinary excretion of twenty peptides forms an early and accurate diagnostic pattern of acute kidney injury.","volume":"78","author":"Metzger","year":"2010","journal-title":"Kidney Int"},{"issue":"9","key":"2019111807521444600_B68","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1111\/j.1537-2995.2009.02217.x","article-title":"Posttransplant thrombotic microangiopathy: sensitivity of proposed new diagnostic criteria.","volume":"49","author":"Kennedy","year":"2009","journal-title":"Transfusion"},{"issue":"2","key":"2019111807521444600_B69","doi-asserted-by":"crossref","first-page":"183","DOI":"10.2165\/00003495-200969020-00004","article-title":"Thrombotic microangiopathy in haematopoietic stem cell transplantation: diagnosis and treatment.","volume":"69","author":"Choi","year":"2009","journal-title":"Drugs"},{"issue":"4","key":"2019111807521444600_B70","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/bmt.2009.233","article-title":"Transplantation-associated thrombotic microangiopathy: effect of concomitant GVHD on efficacy of therapeutic plasma exchange.","volume":"45","author":"Kennedy","year":"2010","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"2019111807521444600_B71","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/sj.bmt.1703414","article-title":"Defibrotide as a promising treatment for thrombotic thrombocytopenic purpura in patients undergoing bone marrow transplantation.","volume":"29","author":"Corti","year":"2002","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"2019111807521444600_B72","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.bbmt.2006.11.020","article-title":"Transplant-associated microangiopathy in patients receiving tacrolimus following allogeneic stem cell transplantation: risk factors and response to treatment.","volume":"13","author":"Oran","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"issue":"10","key":"2019111807521444600_B73","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1097\/01.TP.0000141363.81600.0D","article-title":"Thrombotic microangiopathy after allogeneic blood and marrow transplantation is associated with dose-intensive myeloablative conditioning regimens, unrelated donor, and methylprednisolone T-cell depletion.","volume":"78","author":"Hahn","year":"2004","journal-title":"Transplantation"},{"issue":"2","key":"2019111807521444600_B74","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/j.1537-2995.2008.02030.x","article-title":"Complications of plasma exchange in patients treated for thrombotic thrombocytopenic purpura, IV: an additional study of 43 consecutive patients, 2005 to 2008.","volume":"49","author":"Nguyen","year":"2009","journal-title":"Transfusion"},{"issue":"5","key":"2019111807521444600_B75","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/jca.20143","article-title":"Complications of therapeutic plasma exchange: a prospective study of 1,727 procedures.","volume":"22","author":"Shemin","year":"2007","journal-title":"J Clin Apher"},{"issue":"9674","key":"2019111807521444600_B76","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/S0140-6736(09)60237-3","article-title":"Graft-versus-host disease.","volume":"373","author":"Ferrara","year":"2009","journal-title":"Lancet"},{"issue":"6","key":"2019111807521444600_B77","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/sj.bmt.1705454","article-title":"Replacement of calcineurin inhibitors with daclizumab in patients with transplantation-associated microangiopathy or renal insufficiency associated with graft-versus-host disease.","volume":"38","author":"Wolff","year":"2006","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"2019111807521444600_B78","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1053\/j.ajkd.2004.10.018","article-title":"Successful plasma therapy for atypical hemolytic uremic syndrome caused by factor H deficiency owing to a novel mutation in the complement cofactor protein domain 15.","volume":"45","author":"Licht","year":"2005","journal-title":"Am J Kidney Dis"},{"issue":"1292","key":"2019111807521444600_B79","first-page":"72","article-title":"Successful treatment of transplant-associated microangiopathy with rituximab.","volume":"122","author":"Marr","year":"2009","journal-title":"N Z Med J"},{"issue":"12","key":"2019111807521444600_B80","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/bmt.2008.25","article-title":"Rituximab for allo-SCT-associated thrombotic thrombocytopenic purpura.","volume":"41","author":"Carella","year":"2008","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"2019111807521444600_B81","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1365-2141.2007.06588.x","article-title":"Successful treatment of thrombotic microangiopathy after haematopoietic stem cell transplantation with rituximab.","volume":"137","author":"Au","year":"2007","journal-title":"Br J Haematol"},{"issue":"4","key":"2019111807521444600_B82","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/bmt.2009.242","article-title":"Successful treatment of transplantation-associated thrombotic microangiopathy with recombinant human soluble thrombomodulin.","volume":"45","author":"Sakai","year":"2010","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"2019111807521444600_B83","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/jca.20216","article-title":"Thrombotic microangiopathy during peripheral blood stem cell mobilization.","volume":"24","author":"Naina","year":"2009","journal-title":"J Clin Apher"},{"issue":"2\u20133","key":"2019111807521444600_B84","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.molimm.2009.08.032","article-title":"Recent developments in low molecular weight complement inhibitors.","volume":"47","author":"Qu","year":"2009","journal-title":"Mol Immunol"},{"issue":"5","key":"2019111807521444600_B85","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1056\/NEJMc0808527","article-title":"Eculizumab for atypical hemolytic-uremic syndrome.","volume":"360","author":"Nurnberger","year":"2009","journal-title":"N Engl J Med"},{"issue":"3","key":"2019111807521444600_B86","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1681\/ASN.2008111212","article-title":"The case for using albuminuria in staging chronic kidney disease.","volume":"20","author":"Gansevoort","year":"2009","journal-title":"J Am Soc Nephrol"},{"issue":"17","key":"2019111807521444600_B87","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJMoa0902066","article-title":"Strict blood-pressure control and progression of renal failure in children.","volume":"361","author":"Wuhl","year":"2009","journal-title":"N Engl J Med"},{"issue":"9674","key":"2019111807521444600_B88","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/S0140-6736(09)60502-X","article-title":"Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials.","volume":"373","author":"Bohlius","year":"2009","journal-title":"Lancet"},{"issue":"22","key":"2019111807521444600_B89","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1056\/NEJMoa1004383","article-title":"Reduced mortality after allogeneic hematopoietic-cell transplantation.","volume":"363","author":"Gooley","year":"2010","journal-title":"N Engl J Med"},{"issue":"6","key":"2019111807521444600_B90","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/sj.bmt.1705599","article-title":"Acute renal failure after allogeneic myeloablative stem cell transplantation: retrospective analysis of incidence, risk factors and survival.","volume":"39","author":"Kersting","year":"2007","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"2019111807521444600_B91","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1111\/j.1523-1755.2005.00301.x","article-title":"Acute renal failure independently predicts mortality after myeloablative allogeneic hematopoietic cell transplant.","volume":"67","author":"Parikh","year":"2005","journal-title":"Kidney Int"},{"issue":"13","key":"2019111807521444600_B92","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.","volume":"351","author":"Go","year":"2004","journal-title":"N Engl J Med"},{"issue":"4","key":"2019111807521444600_B93","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.bbmt.2009.11.018","article-title":"Hypertension in long-term survivors of pediatric hematopoietic cell transplantation.","volume":"16","author":"Hoffmeister","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"2019111807521444600_B94","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/sj.bmt.1705643","article-title":"Significant increase in end-stage renal disease after hematopoietic stem cell transplantation.","volume":"39","author":"Cohen","year":"2007","journal-title":"Bone Marrow Transplant"},{"issue":"15","key":"2019111807521444600_B95","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1056\/NEJMsa060185","article-title":"Chronic health conditions in adult survivors of childhood cancer.","volume":"355","author":"Oeffinger","year":"2006","journal-title":"N Engl J Med"},{"issue":"4","key":"2019111807521444600_B96","doi-asserted-by":"crossref","first-page":"R204","DOI":"10.1186\/cc2872","article-title":"Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group.","volume":"8","author":"Bellomo","year":"2004","journal-title":"Crit Care"},{"issue":"10","key":"2019111807521444600_B97","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/sj.ki.5002231","article-title":"Modified RIFLE criteria in critically ill children with acute kidney injury.","volume":"71","author":"Akcan-Arikan","year":"2007","journal-title":"Kidney Int"},{"issue":"2","key":"2019111807521444600_B98","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1186\/cc5713","article-title":"Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury.","volume":"11","author":"Mehta","year":"2007","journal-title":"Crit Care"},{"issue":"2","key":"2019111807521444600_B99","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7326\/0003-4819-139-2-200307150-00013","article-title":"National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification.","volume":"139","author":"Levey","year":"2003","journal-title":"Ann Intern Med"},{"issue":"3","key":"2019111807521444600_B100","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1681\/ASN.2008030287","article-title":"New equations to estimate GFR in children with CKD.","volume":"20","author":"Schwartz","year":"2009","journal-title":"J Am Soc Nephrol"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/118\/6\/1452\/1346324\/zh803211001452.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/118\/6\/1452\/1346324\/zh803211001452.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,6]],"date-time":"2024-04-06T22:03:23Z","timestamp":1712441003000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/118\/6\/1452\/29121\/Small-vessels-big-trouble-in-the-kidneys-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,11]]},"references-count":100,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,8,11]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2011-02-321315","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,11]]}}}